Little is yet known about the health effects of nanoparticles on pregnancy. An interdisciplinary team is currently analyzing the risks for babies in the womb. Using a lab model, the researchers were able to determine that certain nanoparticles impair the release of chemical messengers in the placenta and thus the formation of blood vessels. Read […]
Published on June 6, 2024
An FDA analysis of trial data for Eli Lilly’s experimental Alzheimer’s drug donanemab released on Thursday revealed no red flags, but raised questions about safety of the treatment for patients with early-stage disease. The drug is a potential rival to Eisai and Biogen’s… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., […]
Published on June 6, 2024
British scientists have found a weak link in our DNA that may be responsible for 95% of the 1.6 million cases of inflammatory bowel disease (IBD) plaguing Americans. In an exciting leap forward to curing these common and debilitating conditions, the research team also… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, […]
Published on June 6, 2024